Immunai ^Company

Immunai is a biotech company that combines single-cell genomics with machine learning algorithms to map and reprogram the immune system. Their mission is to decode the immune system and its functions using advanced technologies. By leveraging single-cell technologies and machine learning, Immunai creates immune profiles and discovers biomarkers to understand how cells respond to their environment. They are focused on developing next-generation immunomodulatory therapeutics and are open to partnerships with biopharma and academic pioneers. Immunai is located in New York City, San Francisco, and Tel Aviv, Israel.